GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zhongyuan Union Cell & Gene Engineering Corp Ltd (SHSE:600645) » Definitions » EPS without NRI

Zhongyuan Union Cell & Gene Engineering (SHSE:600645) EPS without NRI : ¥0.31 (TTM As of Mar. 2025)


View and export this data going back to 1993. Start your Free Trial

What is Zhongyuan Union Cell & Gene Engineering EPS without NRI?

Zhongyuan Union Cell & Gene Engineering's earnings per share without non-recurring items for the three months ended in Mar. 2025 was ¥0.07. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2025 was ¥0.31.

During the past 12 months, Zhongyuan Union Cell & Gene Engineering's average earnings per share (NRI) Growth Rate was -9.30% per year. During the past 3 years, the average earnings per share (NRI) Growth Rate was 38.70% per year. During the past 10 years, the average earnings per share (NRI) Growth Rate was 0.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Zhongyuan Union Cell & Gene Engineering's EPS without NRI or its related term are showing as below:

SHSE:600645' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -108   Med: -9   Max: 101
Current: 38.7

During the past 13 years, Zhongyuan Union Cell & Gene Engineering's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 101.00% per year. The lowest was -108.00% per year. And the median was -9.00% per year.

SHSE:600645's 3-Year EPS without NRI Growth Rate is ranked better than
80.88% of 1234 companies
in the Biotechnology industry
Industry Median: 10.5 vs SHSE:600645: 38.70

Zhongyuan Union Cell & Gene Engineering's EPS (Diluted) for the three months ended in Mar. 2025 was ¥0.06. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was ¥0.19.

Zhongyuan Union Cell & Gene Engineering's EPS (Basic) for the three months ended in Mar. 2025 was ¥0.06. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2025 was ¥0.19.


Zhongyuan Union Cell & Gene Engineering EPS without NRI Historical Data

The historical data trend for Zhongyuan Union Cell & Gene Engineering's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhongyuan Union Cell & Gene Engineering EPS without NRI Chart

Zhongyuan Union Cell & Gene Engineering Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.45 0.12 0.22 0.27 0.32

Zhongyuan Union Cell & Gene Engineering Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.09 0.10 0.13 0.02 0.07

Competitive Comparison of Zhongyuan Union Cell & Gene Engineering's EPS without NRI

For the Biotechnology subindustry, Zhongyuan Union Cell & Gene Engineering's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhongyuan Union Cell & Gene Engineering's PE Ratio without NRI Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zhongyuan Union Cell & Gene Engineering's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Zhongyuan Union Cell & Gene Engineering's PE Ratio without NRI falls into.


;
;

Zhongyuan Union Cell & Gene Engineering EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.31

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zhongyuan Union Cell & Gene Engineering  (SHSE:600645) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Zhongyuan Union Cell & Gene Engineering EPS without NRI Related Terms

Thank you for viewing the detailed overview of Zhongyuan Union Cell & Gene Engineering's EPS without NRI provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhongyuan Union Cell & Gene Engineering Business Description

Traded in Other Exchanges
N/A
Address
45 East of Tianjin Airport Economic Zone nine, Tianjin, CHN, 300304
Zhongyuan Union Cell & Gene Engineering Corp Ltd is engaged in stem cell technology research, as well as detection and storage sources of stem cells in China. The company insists on the core strategy upon dual-core development of 'cell + gene' with the major businesses covering various cell storage businesses of newborns and adults; the preparation and storage of cord blood hematopoietic stem cells, umbilical cord mesenchymal stem cells, placental pluripotent stem cells, adipose-derived stem cells and immune cells; genetic testing services relating to children's genes.
Executives
Li De Fu Director
Wang Xue Jun senior management
Wang Yong Director
Li Hai Bin Director
He Wei senior management
Li Qiang senior management
Wu Ming Yuan Director
Wang Hui Director
Huang Jia Xue senior management
Cao Hai Feng Director
Han Yue E Director
Liu Yong Jun senior management
Cui Jing Xue Supervisors
Yang Guang Xing senior management
Meng Zhi Hong senior management

Zhongyuan Union Cell & Gene Engineering Headlines

No Headlines